Moderna has said that it expects the immunity induced by its COVID-19 vaccine would be protective against the coronavirus variant reported in the UK. The US-based company added that it plans to perform additional tests to confirm the vaccine's activity against any strain. The US and Canada recently approved the vaccine for widespread use.